Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel–Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127)

Sounak Gupta, Jun Zhang, Dragana Milosevic, John R. Mills, Stefan K. Grebe, Steven C. Smith, Lori A. Erickson

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Alterations of von Hippel-Lindau (VHL), succinate dehydrogenase (SDHX), and TMEM127 have been associated with the development of pheochromocytomas (PCs) and paragangliomas (PGLs) and are also associated with the development of renal neoplasms. This study involved 2 primary renal PGL and 12 cases of PC/PGL with associated renal neoplasia with a mean follow up of 74 months. Germline VHL and SDHX mutation status was obtained from the medical record. Immunohistochemistry for SDHB and mutation analysis for TMEM127 was performed, in addition to analysis of The Cancer Genome Atlas datasets for SDHX and TMEM127 mutated renal cell carcinomas (RCCs). The spectrum of renal neoplasia included clear cell and tubulocystic and papillary RCC, as well as a case of multiple papillary adenomas. Three patients had metastatic PC/PGL and three patients had VHL syndrome. Previously unreported TMEM127 alterations were identified in two patients, both without evidence of VHL syndrome or SDH-deficiency, and were classified as variants of uncertain significance. Primary renal PGL and neoplasia was associated with about 2% of 710 cases of PC/PGL. These were diagnosed concurrently or on average 27 months prior to the PC/PGL, and most were low-grade, low-stage clear cell RCCs. Up to half of patients with PC/PGL and renal neoplasia had VHL syndrome, SDH deficiency, or alterations in TMEM127. One (of three) case of metastatic PC/PGL had SDHB mutation and loss of SDHB by immunohistochemistry. The other two cases had retained SDHB expression.

Original languageEnglish (US)
Pages (from-to)1-16
Number of pages16
JournalEndocrine Pathology
DOIs
StateAccepted/In press - Jun 23 2017

Fingerprint

Paraganglioma
Succinate Dehydrogenase
Pheochromocytoma
Kidney
Renal Cell Carcinoma
Neoplasms
Proteins
Mutation
Immunohistochemistry
Atlases
Kidney Neoplasms
Adenoma
Medical Records
Genome

Keywords

  • Paraganglioma
  • Pheochromocytoma
  • Renal cell carcinoma
  • SDHA
  • SDHAF1
  • SDHAF2
  • SDHB
  • SDHC
  • SDHD
  • Succinate dehydrogenase
  • TMEM127
  • VHL
  • Von Hippel–Lindau

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma : Analysis of von Hippel–Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). / Gupta, Sounak; Zhang, Jun; Milosevic, Dragana; Mills, John R.; Grebe, Stefan K.; Smith, Steven C.; Erickson, Lori A.

In: Endocrine Pathology, 23.06.2017, p. 1-16.

Research output: Contribution to journalArticle

@article{125bfbbd0c544cf88cc9f4ad529fc0c4,
title = "Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel–Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127)",
abstract = "Alterations of von Hippel-Lindau (VHL), succinate dehydrogenase (SDHX), and TMEM127 have been associated with the development of pheochromocytomas (PCs) and paragangliomas (PGLs) and are also associated with the development of renal neoplasms. This study involved 2 primary renal PGL and 12 cases of PC/PGL with associated renal neoplasia with a mean follow up of 74 months. Germline VHL and SDHX mutation status was obtained from the medical record. Immunohistochemistry for SDHB and mutation analysis for TMEM127 was performed, in addition to analysis of The Cancer Genome Atlas datasets for SDHX and TMEM127 mutated renal cell carcinomas (RCCs). The spectrum of renal neoplasia included clear cell and tubulocystic and papillary RCC, as well as a case of multiple papillary adenomas. Three patients had metastatic PC/PGL and three patients had VHL syndrome. Previously unreported TMEM127 alterations were identified in two patients, both without evidence of VHL syndrome or SDH-deficiency, and were classified as variants of uncertain significance. Primary renal PGL and neoplasia was associated with about 2{\%} of 710 cases of PC/PGL. These were diagnosed concurrently or on average 27 months prior to the PC/PGL, and most were low-grade, low-stage clear cell RCCs. Up to half of patients with PC/PGL and renal neoplasia had VHL syndrome, SDH deficiency, or alterations in TMEM127. One (of three) case of metastatic PC/PGL had SDHB mutation and loss of SDHB by immunohistochemistry. The other two cases had retained SDHB expression.",
keywords = "Paraganglioma, Pheochromocytoma, Renal cell carcinoma, SDHA, SDHAF1, SDHAF2, SDHB, SDHC, SDHD, Succinate dehydrogenase, TMEM127, VHL, Von Hippel–Lindau",
author = "Sounak Gupta and Jun Zhang and Dragana Milosevic and Mills, {John R.} and Grebe, {Stefan K.} and Smith, {Steven C.} and Erickson, {Lori A.}",
year = "2017",
month = "6",
day = "23",
doi = "10.1007/s12022-017-9489-0",
language = "English (US)",
pages = "1--16",
journal = "Endocrine Pathology",
issn = "1046-3976",
publisher = "Humana Press",

}

TY - JOUR

T1 - Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma

T2 - Analysis of von Hippel–Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127)

AU - Gupta, Sounak

AU - Zhang, Jun

AU - Milosevic, Dragana

AU - Mills, John R.

AU - Grebe, Stefan K.

AU - Smith, Steven C.

AU - Erickson, Lori A.

PY - 2017/6/23

Y1 - 2017/6/23

N2 - Alterations of von Hippel-Lindau (VHL), succinate dehydrogenase (SDHX), and TMEM127 have been associated with the development of pheochromocytomas (PCs) and paragangliomas (PGLs) and are also associated with the development of renal neoplasms. This study involved 2 primary renal PGL and 12 cases of PC/PGL with associated renal neoplasia with a mean follow up of 74 months. Germline VHL and SDHX mutation status was obtained from the medical record. Immunohistochemistry for SDHB and mutation analysis for TMEM127 was performed, in addition to analysis of The Cancer Genome Atlas datasets for SDHX and TMEM127 mutated renal cell carcinomas (RCCs). The spectrum of renal neoplasia included clear cell and tubulocystic and papillary RCC, as well as a case of multiple papillary adenomas. Three patients had metastatic PC/PGL and three patients had VHL syndrome. Previously unreported TMEM127 alterations were identified in two patients, both without evidence of VHL syndrome or SDH-deficiency, and were classified as variants of uncertain significance. Primary renal PGL and neoplasia was associated with about 2% of 710 cases of PC/PGL. These were diagnosed concurrently or on average 27 months prior to the PC/PGL, and most were low-grade, low-stage clear cell RCCs. Up to half of patients with PC/PGL and renal neoplasia had VHL syndrome, SDH deficiency, or alterations in TMEM127. One (of three) case of metastatic PC/PGL had SDHB mutation and loss of SDHB by immunohistochemistry. The other two cases had retained SDHB expression.

AB - Alterations of von Hippel-Lindau (VHL), succinate dehydrogenase (SDHX), and TMEM127 have been associated with the development of pheochromocytomas (PCs) and paragangliomas (PGLs) and are also associated with the development of renal neoplasms. This study involved 2 primary renal PGL and 12 cases of PC/PGL with associated renal neoplasia with a mean follow up of 74 months. Germline VHL and SDHX mutation status was obtained from the medical record. Immunohistochemistry for SDHB and mutation analysis for TMEM127 was performed, in addition to analysis of The Cancer Genome Atlas datasets for SDHX and TMEM127 mutated renal cell carcinomas (RCCs). The spectrum of renal neoplasia included clear cell and tubulocystic and papillary RCC, as well as a case of multiple papillary adenomas. Three patients had metastatic PC/PGL and three patients had VHL syndrome. Previously unreported TMEM127 alterations were identified in two patients, both without evidence of VHL syndrome or SDH-deficiency, and were classified as variants of uncertain significance. Primary renal PGL and neoplasia was associated with about 2% of 710 cases of PC/PGL. These were diagnosed concurrently or on average 27 months prior to the PC/PGL, and most were low-grade, low-stage clear cell RCCs. Up to half of patients with PC/PGL and renal neoplasia had VHL syndrome, SDH deficiency, or alterations in TMEM127. One (of three) case of metastatic PC/PGL had SDHB mutation and loss of SDHB by immunohistochemistry. The other two cases had retained SDHB expression.

KW - Paraganglioma

KW - Pheochromocytoma

KW - Renal cell carcinoma

KW - SDHA

KW - SDHAF1

KW - SDHAF2

KW - SDHB

KW - SDHC

KW - SDHD

KW - Succinate dehydrogenase

KW - TMEM127

KW - VHL

KW - Von Hippel–Lindau

UR - http://www.scopus.com/inward/record.url?scp=85021185603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021185603&partnerID=8YFLogxK

U2 - 10.1007/s12022-017-9489-0

DO - 10.1007/s12022-017-9489-0

M3 - Article

AN - SCOPUS:85021185603

SP - 1

EP - 16

JO - Endocrine Pathology

JF - Endocrine Pathology

SN - 1046-3976

ER -